Activity of gemcitabine in patients with non-small cell lung cancer: A multicentre, extended phase II study-Reference-Cited by-同舟云学术

Activity of gemcitabine in patients with non-small cell lung cancer: A multicentre, extended phase II study

Published:1996-02 Issue:2 Volume:32 Page:243-248
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Gatzemeier U.,Shepherd F.A.,Le Chevalier T.,Weynants P.,Cottier B.,Groen H.J.M.,Rosso R.,Mattson K.,Cortes-Funes H.,Tonato M.,Burkes R.L.,Gottfried M.,Voi M.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference33 articles.

1. An analysis of 134 phase II trials in nno-small cell lung cancer (NSCLC);Kris;World Conference on Lung Cancer,1986

2. A review of etoposide in patients with non-small cell lung cancer (NSCLC);Itri;Cancer Treat Rev,1982

3. Cancer of the lung;Ginsberg,1993

4. Action of 2′,2′-difluorodeoxycytidine on DNA synthesis;Huang;Cancer Res,1991

5. 2′,2′-Difluorodeoxycytidine metabolism and mechanism of action in human leukaemia cells;Plunkett;Nucleosides Nucleotides,1989

Cited by 224 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Deciphering disulfidptosis: Uncovering a lncRNA-based signature for prognostic assessment, personalized immunotherapy, and therapeutic agent selection in lung adenocarcinoma patients;Cellular Signalling;2024-05

2. Crosstalk between copper homeostasis and cuproptosis reveals a lncRNA signature to prognosis prediction, immunotherapy personalization, and agent selection for patients with lung adenocarcinoma;Aging;2023-11-26

3. Phase III study of adjuvant gemcitabine compared with adjuvant uracil-tegafur in patients with completely resected pathological stage IB–IIIA non-small cell lung cancer (WJTOG0101);International Journal of Clinical Oncology;2021-08-31

4. The recent advancement of low-dimensional nanostructured materials for drug delivery and drug sensing application: A brief review;Journal of Molecular Liquids;2020-12

5. Gemcitabine induces apoptosis and autophagy via the AMPK/mTOR signaling pathway in pancreatic cancer cells;Biotechnology and Applied Biochemistry;2018-04-16